title: [Bullous toxidermatosis and HIV infection in hospital environment in Lome (Togo)].
abstract: A transversal study allowed to analyse the different features of severe bullous toxicodermatosis, and its relations with HIV infection. Since March 1992 to December 1995, 15 patients were hospitalized in Lome Teaching Hospital for severe bullous toxicodermatosis: 16 cases of Lyell's syndrome, 8 cases of Stevens-Johnson's syndrome and 1 case of ectodermosis. The principal drug which induced these diseases were mostly dominated by the sulfanilamide (n = 7). Nine (9) of these subjects were infected by the HIV (four of whose patients had Lyell's syndrome). Its noted five cases of death, all in the patients with HIV infection.
authors.affiliation: Service de dermatologie-vénéréologie, CHU-Tokion, Lomé, Togo.
authors.forename: P
authors.initials: P
authors.lastname: Pitche
authors.forename: S
authors.initials: S
authors.lastname: Ategbo
authors.forename: A
authors.initials: A
authors.lastname: Gbadoe
authors.forename: A
authors.initials: A
authors.lastname: Bassuka-Parent
authors.forename: B
authors.initials: B
authors.lastname: Mouzou
authors.forename: K
authors.initials: K
authors.lastname: Tchangaï-Walla
mesh_terms: D000328:Adult; D002648:Child; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006760:Hospitalization; D006801:Humans; D008297:Male; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000150:complications; D013262:Stevens-Johnson Syndrome / Q000150:complications; D000077145:Sulfanilamide; D013424:Sulfanilamides / Q000009:adverse effects; D014037:Togo
chemical_list: D013424:Sulfanilamides; D000077145:Sulfanilamide